Abstract:Objective To investigate the change of extracellular histone level as well as the mecha-nism of the cytotoxicity of extracellular histones on vascular endothelial cell in sepsis. Methods Septic chil-dren admitted to PICU in Shanghai Children′s Medical Center between January 2010 and December 2014 were included in the present study. According to the diagnostic criteria of sepsis,the patients were divided into the sepsis group(51 cases) and the severe sepsis group(79 cases),with healthy children as the control group (108 cases). Patients in the severe sepsis group were further divided into the survival group(45 cases) and the non-survival group ( 34 cases ) based on 28-day mortality. The plasma concentration of extracellular histones in these children was determined and its correlation with the severity of sepsis was analyzed. Human umbilical vein endothelial cells(HUVECs) were incubated with calf thymus histone(CTH) at various con-centrations(0,50,100,200 and 300μg/ml) or different time periods(200μg/ml,0,5,15,30,45 and 60 mi-nutes) . The treated cells were subject to flow cytometer to measure the cell survival rate and scanning/trans-mission electron microscopy to observe their morphological changes. Western blot was used to detect the ex-pression of IκB and phosphor-p38/p38 in nuclear factor ( NF )-κB and mitogen-activated protein kinase ( MAPK) signaling pathways,while ELISA was used to determine the levels of tumor necrosis factor-α and interleukin-6. Results The levels of circulating histones in the septic children(2. 29 ± 1. 00) and severe sep-tic children ( 19. 17 ± 10. 20 ) were significantly higher than that of healthy controls ( 0. 23 ± 0. 26 ) ( P <0. 001),and the histone levels in the severe septic children were even higher(P<0. 001). Among the chil-dren diagnosed as severe sepsis,the level of circulating histones in the non-survivors was significantly higher than that in the survivors(29. 47 ± 5. 99 vs. 10. 94 ± 2. 68,P<0. 001). The survival rate of HUVEC gradually decreased along with the increase of CTH concentration or the treatment period in vitro. Data from electron microscopy showed that CTH treatment could directly disrupt the plasma membrane of HUVEC. Histones could also activate NF-κB and MAPK pathways,leading to the release of large amount of tumor necrosis fac-tor-α and interleukin-6. Conclusion The levels of extracellular histones in the septic children are correlated with the severity of sepsis. CTH can induce HUVEC death in a dose-and time-dependent manner. Extracellu-lar histone-induced endothelial dysfunction may mediate the progression of sepsis and such cytotoxicity might be due to the destruction of endothelial cell membranes and activation of the NF-κB and MAPK signaling pathways.

Expression of HMGB1 in septic serum induces vascular endothelial hyperpermeability.

CXCL13 is Involved in the Lipopolysaccharide-Induced Hyperpermeability of Umbilical Vein Endothelial Cells

HMGB1 Increases Permeability of the Endothelial Cell Monolayer via RAGE and Src Family Tyrosine Kinase Pathways

M1 Macrophages Increase Endothelial Permeability and Enhance P38 Phosphorylation Via PPAR-γ/CXCL13-CXCR5 in Sepsis.

Effect of HMGB 1 on endothelial cells in sepsis

Study on Relationship Between Vascular Endothelial Cells Hyperpermeability Induced by Serum of Patients with Sepsis and Relative Factors

HMGB1, a potent proinflammatory cytokine in sepsis.

Septic serum mediates inflammatory injury in human umbilical vein endothelial cells via reactive oxygen species, mitogen activated protein kinases and nuclear factor‐κB

Therapeutic Potential of HMGB1-targeting Agents in Sepsis.

Severity of Sepsis is Correlated with the Elevation of Serum High-Mobility Group Box 1 in Rats.

HMGB1 Turns Renal Tubular Epithelial Cells into Inflammatory Promoters by Interacting with TLR4 During Sepsis

Novel Insights For High Mobility Group Box 1 Protein-Mediated Cellular Immune Response In Sepsis: A Systemic Review

Loss Of Caveolin-1 Promotes Endothelial-Mesenchymal Transition During Sepsis: A Membrane Proteomic Study

Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury

Pathophysiological Function of HMGB1 As a Late- Acting Mediator of Inflammation

HMGB1 producing by viable cardiac fibroblasts led to myocardial contractile dysfunction via PKC-β/Erk1/2/CBP Signal Pathway (174.21)

Inflammatory Response and Immune Regulation of High Mobility Group Box-1 Protein in Treatment of Sepsis.

Hemolysin Sph2 from Leptospira interrogans amplified inflammatory response in murine macrophages J774A.1 through HMGB1

Cytotoxicity of Extracellular Histones on Vascular Endothelial Cells and the Underlying Mechanisms in Sepsis

The potential role of HMGB1 release in peritoneal dialysis-related peritonitis.

High-Mobility Group Box 1 Protein Induces Tissue Factor Expression in Vascular Endothelial Cells Via Activation of Nf-Kappa B and Egr-1